TCM
MDXG icon

Teza Capital Management’s MiMedx Group MDXG Stock Holding History

Teza Capital Management’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,433
Closed -$80.3K – 691
2024
Q1 		$80.3K Buy
+10,433
New +$83.9K 0.01% 544

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Teza Capital Management's MDXG Position: Q2 2024 in Review

Teza Capital Management sold out of MiMedx Group (MDXG) in Q2 2024, closing a stake of 10,433 shares — an estimated $80.3K sold.

Teza Capital Management first reported a position in MDXG in Q1 2024 and held it in 1 quarter. The position peaked at $80.3K in Q1 2024. 202 funds tracked by Wall St. Rank hold MDXG as of Q2 2024.

  • Teza Capital Management reported no remaining MiMedx Group position as of Q2 2024 after selling out during the quarter.
  • Teza Capital Management sold 10,433 MiMedx Group shares in Q2 2024, an estimated $80.3K.
  • Teza Capital Management first reported a position in MiMedx Group in Q1 2024 and held it in 1 quarter.
  • Teza Capital Management's MiMedx Group position peaked at $80.3K in Q1 2024.
  • 202 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2024.

Based on Teza Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.